Biofrontera AG Profit Margin 2017-2021 | BFRA
Current and historical gross margin, operating margin and net profit margin for Biofrontera AG (BFRA) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Biofrontera AG net profit margin as of June 30, 2021 is -59.7%.
|Biofrontera AG Annual Profit Margins
|Biofrontera AG Quarterly Profit Margins
||Medical - Biomedical and Genetics
Biofrontera AG is a biopharmaceutical company. It engaged in the development and commercialization of a platform of pharmaceutical products for the treatment of dermatological conditions and diseases. The company's products focus on the treatment in the U.S. and Europe of actinic keratoses, which are skin lesions which can sometimes lead to skin cancer as well as the treatment of certain forms of basal cell carcinoma in the European Union. Biofrontera AG is based in Leverkusen, Germany.